Biocon And Mylan's Fulphila And Insulin Plans On Track

FDA Expected To Inspect Malaysia Insulins Facility In February

 
• By Anju Ghangurde
  
Hands holding rope forming arrow pointing upwards - Image
Momentum For Biocon-Mylan Biosimilars Portfolio • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products